Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 189453-10-9, Desoxyepothilone b, (-)-desoxyepothilone b, Kos-862, 12,13-desoxyepothilone b, (-)-epothilone d
Molecular Formula
C27H41NO5S
Molecular Weight
491.7  g/mol
InChI Key
XOZIUKBZLSUILX-GIQCAXHBSA-N
FDA UNII
T0358E0YUF

microtubule-targeted antitumor agent; lacking the epoxide of epothilone B; may be equiv to epothilone D
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4S,7R,8S,9S,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
2.1.2 InChI
InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1
2.1.3 InChI Key
XOZIUKBZLSUILX-GIQCAXHBSA-N
2.2 Other Identifiers
2.2.1 UNII
T0358E0YUF
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Desoxyepothilone B

2. 12,13-desoxyepothilone B

3. Depob Cpd

4. Epothilon D

5. Epothiolone D

6. Epothilone B, Desoxy

7. Kos 862

8. Kos-862

9. Kos862

2.3.2 Depositor-Supplied Synonyms

1. 189453-10-9

2. Desoxyepothilone B

3. (-)-desoxyepothilone B

4. Kos-862

5. 12,13-desoxyepothilone B

6. (-)-epothilone D

7. Epothilon D

8. Nsc-703147

9. Kos 862

10. 12,13-deoxyepothilone B

11. Epothiolone D

12. Depob Cpd

13. Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-, (4s,7r,8s,9s,13z,16s)-

14. Nsc 703147

15. T0358e0yuf

16. Epothilone B, Desoxy

17. 12,13-desoxyepothilone B, Cis

18. Kos862

19. R1492

20. Chebi:29579

21. Dtxsid70880053

22. Nsc703147

23. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

24. Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-((1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (4s,7r,8s,9s,13z,16s)-

25. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-((e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl)-1-oxacyclohexadec-13-ene-2,6-dione

26. Refchem:137339

27. Dtxcid901022595

28. (4s-(4r*,7s,8r*,9r*,13z,16r*(e)))-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)oxacyclohexadec-13-ene-2,6-dione

29. R-1492

30. Mfcd27976357

31. (4s,7r,8s,9s,16s,z)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-((e)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)oxacyclohexadec-13-ene-2,6-dione

32. Epothilone D (synthetic)

33. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(e)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-1-oxacyclohexadec-13-ene-2,6-dione

34. Epd

35. Unii-t0358e0yuf

36. Utidelone

37. Epothilone-d

38. Depob

39. Utidelone [inn]

40. Epo D

41. Epothilone D [mi]

42. Schembl4415

43. 12,13-desoxy-epothilone B

44. Chembl96172

45. Z-12,13-desoxyepothilone B

46. Epothilone D [who-dd]

47. C27h41no5s

48. Orb1679023

49. Ex-a495

50. Glxc-06445

51. Biologically Synthesized Epothilone D

52. Lmpk04000001

53. Nsc721085

54. Akos025401598

55. Cs-0655

56. Db01873

57. Fe22752

58. Nsc-721085

59. Ac-22616

60. Hy-15278

61. Brd-k52762805-001-01-2

62. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-(1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl-oxacyclohexadec-13-ene-2,6-dione

63. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

64. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]oxacyclohexadec-13-ene-2,6-dione

65. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]oxacyclohexadec-13-ene- 2,6-dione

66. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]oxacyclohexadec-13-ene-2,6-dione; (-)-desoxyepothilone B; (-)-epothilone D; 12,13-deoxyepo

67. (4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(e)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]oxacyclohexadec-13-ene-2,6-dione

68. (4s-(4r*,8r*,9r*,13z,16r*(e)))-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)oxacyclohexadec-13-ene-2,6-dione

69. Oxacyclohexadec-13-ene-2,6-dione, 4,6-dihydroxy-5,5,7,9,13-pentamethyl-16-((1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (4s,7r,8s,9s,13z,16s)-

70. Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (4s-(4r*,7s,8r*,9r*,13z,16r*(e)))-

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 491.7 g/mol
Molecular Formula C27H41NO5S
XLogP35
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count2
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area125
Heavy Atom Count34
Formal Charge0
Complexity777
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in colorectal cancer, lung cancer, breast cancer, solid tumors, and prostate cancer.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Tubulin Modulators

Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES.


5.2 ATC Code

L - Antineoplastic and immunomodulating agents

L01 - Antineoplastic agents

L01D - Cytotoxic antibiotics and related substances

L01DC - Other cytotoxic antibiotics

L01DC05 - Utidelone


ATCvet Code

QL - Antineoplastic and immunomodulating agents

QL01 - Antineoplastic agents

QL01D - Cytotoxic antibiotics and related substances

QL01DC - Other cytotoxic antibiotics

QL01DC05 - Utidelone


5.3 Mechanism of Action

The principal mechanism of the epothilone class is inhibition of microtubule function. Microtubules are essential to cell division, and epothilones therefore stop cells from properly dividing.